ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,917.88
0.20%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. La Jolla Pharmaceutical Company (LJPC)

  7. La Jolla Pharmaceutical Company (LJPC) News

La Jolla Pharmaceutical (LJPC)

La Jolla Pharmaceutical Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LJPC
DateTimeSourceHeadlineSymbolCompany
14/02/202315:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
01/09/202213:39Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LJPCLa Jolla Pharmaceutical Company
29/08/202217:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
29/08/202217:10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:LJPCLa Jolla Pharmaceutical Company
23/08/202222:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
23/08/202222:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
23/08/202222:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
23/08/202222:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
23/08/202222:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202214:32Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202214:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202214:20Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202214:09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202213:55Business WireInnoviva Completes Acquisition of La Jolla PharmaceuticalNASDAQ:LJPCLa Jolla Pharmaceutical Company
15/08/202213:14Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
15/08/202213:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LJPCLa Jolla Pharmaceutical Company
25/07/202213:40Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LJPCLa Jolla Pharmaceutical Company
25/07/202213:35Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LJPCLa Jolla Pharmaceutical Company
12/07/202211:10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:LJPCLa Jolla Pharmaceutical Company
12/07/202211:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
11/07/202220:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LJPCLa Jolla Pharmaceutical Company
11/07/202212:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LJPCLa Jolla Pharmaceutical Company
11/07/202212:32Business WireInnoviva to Acquire La Jolla Pharmaceutical CompanyNASDAQ:LJPCLa Jolla Pharmaceutical Company
05/07/202222:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
17/05/202222:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
16/05/202221:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LJPCLa Jolla Pharmaceutical Company
16/05/202221:15Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
18/04/202223:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
18/04/202223:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
04/04/202222:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
 Showing the most relevant articles for your search:NASDAQ:LJPC

Your Recent History

TSXV
BLUE
Blue Thunder Mining
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved